ALEXIS MASSOUD: Open Payments
NPI 1811611841 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 23 payments from 8 companies in 2025. Trend: 2023 $790 · 2024 $654 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $138 |
| Lilly USA, LLC | 5 | $94 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| PFIZER INC. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: MOUNJARO, Wegovy, SHINGRIX, JARDIANCE, Ozempic, ZEPBOUND, PAXLOVID, Veozah.
Industry payments across NJ — which companies pay providers there.
